There’s No Getting Around Baxter International Inc. (NYSE: BAX) Success

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Yahoo Finance discussed the stock recently as it posted Baxter to Host Fourth-Quarter 2023 Financial Results Conference Call for Investors.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Stocks Info

BAX belongs to the Healthcare sector of the NYSE while operating in the Medical Instruments & Supplies industry. At the end of the last regular session, the stock closed at $39.19 and fluctuated between $39.51 as its day high and $38.44 as its day low. The current market capitalization of Baxter International Inc. is $19.88B. A total of 2.84 million shares were traded on the day, compared to an average of 3.99M shares.

Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, BAX has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 37 BUYs and 25 SELLs from insiders. Insiders purchased 473,983 shares during that period but sold 33,982.

In the most recent transaction, STROUCKEN ALBERT P L sold 3,930 shares of BAX for 37.52 per share on Mar 20. After the transaction, the Director now owns 36,835 company shares. In a previous transaction on Feb 21, Kunzler Jacqueline sold 3,813 shares at 40.50 per share. BAX shares that SVP, Chief Quality Officer owns now total 16,725.

Dividend

Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. BAX’s most recent ex-dividend date was 11/30/2023 when it declared a $0.29 quarterly dividend that was paid in cash on 1/2/2024. Previously, the company paid the dividend on 10/2/2023 with an ex-dividend date of 8/31/2023. The BAX stock dividend was $0.29 per share in cash.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for BAX in the last 3 months, the mean price target is $42.33 with high estimates of $52.00 and low estimates of $35.00. In terms of 52-week highs and lows, BAX has a high of $50.21 and a low of $31.01.

As of this writing, BAX has an earnings estimate of $Bank of America Corporation per share for the current quarter. EPS was calculated based on a consensus of Boeing Company (The) estimates, with a high estimate of $Boston Scientific Corporation per share and a lower estimate of $Blackstone Inc.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BAX is Buy with a score of 3.62.

Most Popular

Related Posts